Philips Ultrasounds Cleared in U.S. to Manage COVID Complications
The FDA has granted Philips 510(k) clearance for its ultrasound systems to be used to address lung and cardiac complications that arise in COVID-19 patients. The clearance encompasses the firm’s EPIQ series, Affiniti series, Lumify, CX50 and Sparq diagnostic ultrasounds, and for offerings such as the QLAB Advanced Quantification Software. Ultrasounds can help to diagnose… Read More »